GE HealthCare Technologies (GEHC) Cash from Financing Activities (2022 - 2026)

GE HealthCare Technologies has reported Cash from Financing Activities for 5 years, with the latest figure at $21.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 107.34% year-over-year to $21.0 million; the trailing twelve-month figure through Mar 2026 stood at $924.0 million (up 230.88% YoY), and the FY2025 full-year result was $617.0 million, up 207.68% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $21.0 million, up from -$293.0 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $1.4 billion in Q2 2025, with the low at -$1.3 billion in Q4 2024.
• Historically, Cash from Financing Activities has averaged -$72.6 million across 5 years, with a median of -$153.0 million in 2024.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 2332.43% — and 2024, when it jumped 3908.33%.
• GE HealthCare Technologies' Cash from Financing Activities stood at -$37.0 million in 2022, then plunged by 2332.43% to -$900.0 million in 2023, then slumped by 41.89% to -$1.3 billion in 2024, then surged by 77.06% to -$293.0 million in 2025, then surged by 107.17% to $21.0 million in 2026.
• The last three Cash from Financing Activities figures came in at $21.0 million (Q1 2026), -$293.0 million (Q4 2025), and -$165.0 million (Q3 2025), per Business Quant data.